Switch Therapeutics

Switch Therapeutics is a precision neuroscience biotechnology company founded in 2020 and based in San Francisco, California, developing biomarker-gated genetic medicines for central nervous system (CNS) diseases with high unmet need. Its Conditionally Activated siRNA (CASi) platform combines properties of single- and double-stranded RNAs in one molecule to enable efficient self-delivery, potent and durable gene knockdown, and cell-type/cell-state selectivity. Its lead development candidate is CASi-APOE, a liver-sparing APOE RNAi therapy. The company is backed by CRV and Insight Partners and is a therapeutics developer with no public developer API, SDK, or technical documentation surface.

Switch Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotech, Biotechnology, Pharmaceuticals, and Genetic Medicine.

Switch Therapeutics’ developer surface includes engineering blog and 6 more developer resources.

🌐 Visit website 📡 Source on GitHub
14.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiotechBiotechnologyPharmaceuticalsGenetic MedicineRNAiNeuroscienceLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 14.3/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/switch-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Switch Therapeutics Domain Security

TLSv1.3 · DNSSEC · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 4

The organization behind the API

Website
Website
 Blog
Blog
 Careers
Careers
 LinkedIn
LinkedIn

Source (apis.yml)

apis.yml Raw ↑ 
aid: switch-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/switch-therapeutics.png
name: Switch Therapeutics
description: Switch Therapeutics is a precision neuroscience biotechnology company founded in 2020 and based in San Francisco,
  California, developing biomarker-gated genetic medicines for central nervous system (CNS) diseases with high unmet need.
  Its Conditionally Activated siRNA (CASi) platform combines properties of single- and double-stranded RNAs in one molecule
  to enable efficient self-delivery, potent and durable gene knockdown, and cell-type/cell-state selectivity. Its lead development
  candidate is CASi-APOE, a liver-sparing APOE RNAi therapy. The company is backed by CRV and Insight Partners and is a therapeutics
  developer with no public developer API, SDK, or technical documentation surface.
url: https://raw.githubusercontent.com/api-evangelist/switch-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- crv
- insight-partners
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Biotech
- Biotechnology
- Pharmaceuticals
- Genetic Medicine
- RNAi
- Neuroscience
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/switch-therapeutics-domain-security.yml
- type: Website
  url: https://www.switchthera.com/
- type: Blog
  url: https://www.switchthera.com/news/
- type: PrivacyPolicy
  url: https://www.switchthera.com/privacy-policy
- type: TermsOfService
  url: https://www.switchthera.com/terms
- type: Careers
  url: https://www.switchthera.com/careers/
- type: LinkedIn
  url: https://www.linkedin.com/company/switch-therapeutics
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1